Benitec Biopharma Limited Share Price Australian S.E.
Equities
BLT
AU000000BLT8
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 115M 75.74M 6.04B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.58
x | P/E ratio 2025 * |
-4.98
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.88% |
Managers | Title | Age | Since |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 30/09/16 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/15 |
Megan Boston
CMP | Compliance Officer | 52 | 31/07/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 31/03/13 |
Edward Smith
BRD | Director/Board Member | 53 | 13/04/20 |
Peter Francis
BRD | Director/Board Member | 68 | 31/01/06 |
1st Jan change | Capi. | |
---|---|---|
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |